Zymeworks, Inc.
(NYSE : ZYME)

( )
ZYME PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co. 0.30%66.981.0%$730.28m
JNJJohnson & Johnson -0.02%148.200.7%$717.89m
PFEPfizer Inc. 0.05%40.620.9%$621.64m
MRKMerck & Co., Inc. 0.56%91.690.7%$588.02m
ABBVAbbVie, Inc. 0.32%89.552.3%$541.23m
LLYEli Lilly & Co. 0.21%141.411.1%$422.89m
APLSApellis Pharmaceuticals, Inc. -3.99%40.380.0%$108.01m
AZNAstraZeneca Plc 2.48%51.751.2%$100.90m
NVSNovartis AG 0.52%95.610.2%$99.34m
GSKGlaxoSmithKline Plc 2.28%48.230.2%$82.94m
SNYSanofi 0.29%51.340.2%$75.60m
NVONovo Nordisk A/S 0.54%61.620.1%$67.44m
RETAReata Pharmaceuticals, Inc. 1.80%216.273.5%$67.01m
KRTXKaruna Therapeutics, Inc. -0.43%95.330.0%$59.01m
TPTXTurning Point Therapeutics, Inc. 8.38%58.360.0%$41.00m

Company Profile

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.